Amifostine protection against doxorubicin cardiotoxicity in rats. - Wikidata - awgldk - TriplyDB

Amifostine protection against doxorubicin cardiotoxicity in rats.

Amifostine protection against doxorubicin cardiotoxicity in rats.

http://www.wikidata.org/entity/Q44838553

about

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury.Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.Anthracycline Chemotherapy and Cardiotoxicity.Amifostine Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.Protective effect of amifostine on busulfan induced DNA damage in human hepatoma cells.Effects of ionizing radiation on the heart.Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity.Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats.Activity of dexrazoxane and amifostine against late cardiotoxicity induced by the combination of doxorubicin and cyclophosphamide in vivo.Angelica sinensis: a novel adjunct to prevent doxorubicin-induced chronic cardiotoxicity.Doxorubicin-induced changes of ventricular repolarization heterogeneity: results of a chronic rat study.Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats

P2860

Q24628695-518E6567-FDDC-478A-BDB8-9FB6233DF542 Q28258783-8F277C15-C97C-4E26-9B5E-B51BCC7B89E1 Q30539903-0F76234A-7129-4B19-A408-A1F2500E5CC9 Q34563378-978401E8-C8E9-461A-A9E7-3A451CF992AF Q36153375-B4A84F4C-3C75-4582-A07D-455EFF527353 Q37694541-8F885BCD-56DB-48E0-BE71-9778061888D2 Q37723707-A946718E-910E-4F2E-8DB5-A4DC06956BE5 Q38109236-6BF95FA1-284C-4544-A3B5-622C50644CFF Q38738226-C25D53D3-54F2-4ACC-8BB1-A7E9C7548833 Q39029699-B12737CF-1EBF-4F25-A18A-E8578FACC8FF Q40108911-23B2D474-AC46-4584-82F6-FDA6C843A947 Q46253112-FAA16CF1-D131-4CD7-9DBA-656F77300A28 Q46626254-91F0C89E-01D6-4044-832F-402899E1C012 Q46717036-04C32F43-2167-4AB5-984F-A289CB0E4957 Q46923389-70617268-AB3C-4317-A32A-74C17EAE9F06 Q47726932-4AB602BE-2427-423D-BC20-A44EABE7D1F3 Q53723158-B5E2FC98-9859-406A-BA45-41CD688E9C45 Q58787647-36F9774A-24CA-4E04-945C-13A1512BD930

P2860

Amifostine protection against doxorubicin cardiotoxicity in rats.

http://www.wikidata.org/entity/Q44838553

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Amifostine protection against doxorubicin cardiotoxicity in rats.

@en

Amifostine protection against doxorubicin cardiotoxicity in rats.

@nl

type

label

Amifostine protection against doxorubicin cardiotoxicity in rats.

@en

Amifostine protection against doxorubicin cardiotoxicity in rats.

@nl

prefLabel

Amifostine protection against doxorubicin cardiotoxicity in rats.

@en

Amifostine protection against doxorubicin cardiotoxicity in rats.

@nl

P1433

Q44838553-98819B45-DDC3-49E8-856D-33D4EF33880E

P1476

Q44838553-90441CD9-631F-4D74-B09A-BEAF1B7DC3AC

P2093

Q44838553-041E3E99-14ED-404E-8FC5-8883EF7633DF

Q44838553-52403C86-E17E-42F7-8271-4DCC1905633C

Q44838553-A3FCCE78-CC97-4213-866A-BC34A35D0021

Q44838553-ADE77594-8490-4E76-828B-AD238C4186E0

Q44838553-C0085349-1A81-4BA4-94E7-F78D4A5DF94C

Q44838553-EB1EB636-48DC-448E-97E3-DCC15EE9E648

Q44838553-FCD0E104-7EF6-4967-B087-C142F37ACC35

P304

Q44838553-CB2ECA26-C26E-4809-8CBA-A386E0D6B0B0

P31

Q44838553-A5479658-CE91-4845-A806-DD64ED02EA43

P356

Q44838553-56432D2A-BA69-4847-9F94-8BD010CF2643

P433

Q44838553-337DCABD-E871-4713-9088-F2AB43A4266A

P478

Q44838553-6F1E752A-676A-46D6-91AE-0218586460BF

P577

Q44838553-1A75C3CA-2C6B-471D-8215-44A6C467E0C6

P698

Q44838553-A7C095E4-D080-47DB-9D98-044C6238980A

P356

00001813-200402000-00011

P1433

Anti-Cancer Drugs

P1476

Amifostine protection against doxorubicin cardiotoxicity in rats.

@en

P2093

Dubravko R Bokonjic

http://www.w3.org/2001/XMLSchema#string

Nikola P Dogovic

http://www.w3.org/2001/XMLSchema#string

Silva L J Dobric

http://www.w3.org/2001/XMLSchema#string

Snezana M Sinovec

http://www.w3.org/2001/XMLSchema#string

Vesna M Jacevic

http://www.w3.org/2001/XMLSchema#string

Viktorija M Dragojevic-Simic

http://www.w3.org/2001/XMLSchema#string

Zarko M Vucinic

http://www.w3.org/2001/XMLSchema#string

P304

169-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00001813-200402000-00011

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15075674

http://www.w3.org/2001/XMLSchema#string